AODA treatment stands for Alcohol and Other Drug Abuse treatment, a broad term covering the range of professional services designed to help people stop using substances and build a sustainable recovery. The term originated in clinical and insurance settings and remains widely used, though the formal diagnostic language has shifted. Since 2013, the condition it addresses has been classified as “substance use disorder” with severity levels ranging from mild to severe, replacing the older categories of “substance abuse” and “substance dependence.”
Whether you’ve seen “AODA” on an insurance form, a court order, or a treatment center’s website, it refers to the same continuum of care: screening, detoxification when needed, structured therapy, medication support, and long-term aftercare.
How Treatment Levels Are Organized
AODA treatment isn’t one-size-fits-all. The American Society of Addiction Medicine (ASAM) defines five main levels of care, numbered 0.5 through 4, based on how much structure and medical supervision a person needs.
- Level 0.5, Early intervention: Brief education or counseling for people showing early warning signs but not yet meeting criteria for a substance use disorder.
- Level I, Outpatient: One to two sessions per week, one to two hours each. This suits people with a stable home environment and a mild to moderate problem.
- Level II, Intensive outpatient or partial hospitalization: Typically 9 or more hours per week for adults, spread over three to five days. Programs at this level generally run 30 to 90 days, with daily sessions lasting three to six hours. Partial hospitalization programs (PHP) are even more intensive, often around six and a half hours a day, five days a week.
- Level III, Residential or inpatient: The person lives at the treatment facility and receives 24-hour support. Several sub-levels exist depending on medical and psychiatric complexity.
- Level IV, Medically managed inpatient: Hospital-based care for people with severe medical or psychiatric complications requiring round-the-clock physician oversight.
Most people don’t start at the highest level. A clinician determines the right fit based on the substance involved, how long the person has been using, their physical health, mental health history, and social supports at home.
Screening and Assessment
Treatment begins with a structured screening, usually a short questionnaire. Two of the most common tools are the AUDIT for alcohol and the DAST-10 for drugs. The AUDIT is a 10-item questionnaire scored from 0 to 40; a score of 8 or higher signals high risk for an alcohol use disorder. The DAST-10 is also 10 items, and a score of 3 or more suggests the likelihood of a drug use disorder. These aren’t diagnostic on their own, but they help clinicians decide how urgently someone needs intervention and at what level of care.
Medical Detox: The First Step for Some
Not everyone entering AODA treatment needs detox, but for people physically dependent on alcohol, opioids, or certain sedatives, it’s a necessary first phase. Detox is supervised withdrawal, with medical staff available around the clock to monitor vital signs and manage symptoms.
How long detox takes depends on the substance. Alcohol withdrawal typically lasts 2 to 10 days. Heroin and other short-acting opioid withdrawal runs 4 to 10 days, while withdrawal from longer-acting opioids can stretch to 10 to 20 days. Sedative withdrawal (from drugs in the benzodiazepine family) can continue for 2 to 8 weeks or longer. Stimulant withdrawal is shorter, usually 3 to 5 days, though the fatigue and low mood that follow can linger. Cannabis withdrawal, which surprises some people, typically lasts one to two weeks.
During detox, patients are monitored three to four times daily. The goal is to get a person medically stable and comfortable enough to engage in the therapeutic work that follows. Detox alone, without ongoing treatment, rarely leads to lasting recovery.
Medication Support
For opioid and alcohol use disorders, medications can significantly improve outcomes by reducing cravings and preventing relapse. Three medications are FDA-approved specifically for opioid use disorder. One is a partial activator of the brain’s opioid receptors, meaning it provides enough stimulation to ease cravings and withdrawal without producing a full high, and it has a built-in ceiling that limits its effects at higher doses. Another fully activates those receptors at controlled, stable doses, preventing the cycle of highs and crashes. The third works as a blocker: it sits on the opioid receptor and prevents other opioids from having any effect, removing the reward if a person relapses.
That same blocking medication is also approved for alcohol use disorder, where it reduces the pleasurable effects of drinking. Another medication approved for alcohol recovery works differently, helping restore the brain’s chemical balance after prolonged heavy drinking to reduce the discomfort that often drives relapse.
These medications are most effective when combined with counseling, not used in isolation.
Behavioral Therapies
Therapy is the core of AODA treatment at every level. Cognitive behavioral therapy (CBT) is the most widely used approach. It’s rooted in the idea that substance use is tied to specific thought patterns, emotional triggers, and learned behaviors. In treatment, you learn to identify the situations and thinking habits that lead to use, then practice new coping strategies. Relapse prevention training and social skills building are direct adaptations of CBT tailored for addiction.
Group therapy is another staple. Most intensive outpatient and residential programs structure the day around group sessions where participants share experiences, practice interpersonal skills, and hold each other accountable. Individual therapy sessions address personal history, trauma, and goals in a more private setting. Many programs also incorporate family therapy, since substance use disorders affect and are affected by household dynamics.
Co-Occurring Mental Health Conditions
A large number of people in AODA treatment are also dealing with a mental health condition like depression, anxiety, PTSD, or bipolar disorder. According to SAMHSA’s 2024 national survey, roughly 21.2 million adults in the United States had both a mental illness and a substance use disorder at the same time. This is often called dual diagnosis or co-occurring disorders.
Treating only the substance use while ignoring the mental health condition, or vice versa, leads to poorer results. Effective AODA programs screen for co-occurring conditions and address both simultaneously, using integrated treatment plans that combine psychiatric support with addiction-focused therapy. If you’re entering treatment and have a history of mental health symptoms, bringing that up early helps your clinical team design a more effective plan.
Aftercare and Long-Term Recovery
Completing a treatment program is a milestone, not an endpoint. Aftercare, sometimes called continuing care, is the ongoing support structure that follows formal treatment. It typically includes some combination of regular check-in sessions with a counselor, peer support groups, case management for practical needs like housing and employment, and skill-building to handle the stressors of daily life without returning to substance use.
Sober living or recovery housing plays a meaningful role for many people. Research shows that individuals living in halfway or recovery houses after treatment have better retention in continuing care and make greater progress toward their recovery goals compared to those returning directly to their previous living environment. These residences provide structure, accountability, and a substance-free social network during the vulnerable transition period.
Peer-led support meetings, whether 12-step programs or alternative models, give people a consistent community. Many continuing care plans also include professionally led recovery training sessions alongside these peer groups. The combination of professional guidance and lived-experience support addresses both the clinical and social sides of staying in recovery.